Diabetic Foot Ulcer Treatment Market To Reach $9.88 Billion By 2033

Diabetic Foot Ulcer Treatment Market Growth & Trends

The global diabetic foot ulcer treatment market size is expected to reach USD 9.88 billion by 2033, registering a CAGR of 7.06% from 2026 to 2033, according to a new report by Grand View Research, Inc. Diabetes is one of the major causes of amputation, blindness, stroke, end-stage renal failure, kidney failure, and heart attacks in this region. According to the International Diabetes Federation, ~66 million people were suffering from diabetes in Europe in 2017. The number is expected to increase to ~81 million by 2045. The mortality rate associated with DFU is ~5% in the first 12 months and increases up to 42% by the end of 5 years.

Many adjuvant therapies such as nonsurgical debridement agents, dressings and topical agents, oxygen therapies, negative pressure wound therapy, acellular bioproducts, human growth factors, energy-based therapies, and systemic therapies are said to effectively improve and cure DFU. Recent studies suggest that the inhibition of detrimental proteinase MMP-9 enzyme allows the body to heal the wound at a quicker rate. Sedentary lifestyle, poor GDP expenditure on healthcare, unhealthy food habits, and poor reimbursement scenarios in the Asian region are the factors responsible for the high growth of diabetes in this region. Hence, numerous ill effects of DFU are observed in the Asian region.

The biologics segment held the largest revenue share in 2023 and is expected to grow at the highest rate during the forecast period. Biologics include growth factors [such as Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF)], stem cells, and other anti-diabetic drugs. These agents help reduce hyperglycemia, increase oxygenation and circulation, and repair lost tissues. Therefore, they are increasingly being used for the management of wounds in different stages and are considered to be ideal for DFU treatment. Wound care dressings held the second-largest revenue share in 2021, followed by therapy devices and antibiotic medications.

Market players are constantly developing new and improved products to ensure quicker healing time for DFU. Companies like ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast Corp.; and Smith & Nephew Plc. are among the leaders in this market. Despite the Covid-19 outbreak, these players reported an increase in demand for their wound management products due to the increased complications of diabetic patients suffering from Covid-19 infection. The market was said to increase at a steady rate in 2021 as Covid-19 treated patients witnessed a rise in sugar levels leading to the onset of diabetes. For instance, the overall proportion of diabetic patients with Covid-19 ranged from 5% - 30% in Italy in 2020. Further, Smith and Nephew reported the sales of its newly launched wound healing product, PICO 7, to cross the 1 million mark in 2020. Hence, the market grew dramatically in 2020 and is estimated to stabilize during the forecast period.

 Request a free sample copy or view report summary: Diabetic Foot Ulcer Treatment Market Report

Diabetic Foot Ulcer Treatment Market Report Highlights

• The rising geriatric population is a significant driver of the market for diabetic foot ulcer treatment, as older adults are more vulnerable to chronic wounds and delayed healing

• The diabetic foot ulcer treatment industry is witnessing significant innovation, with the development of advanced wound care technologies aimed at improving healing outcomes and reducing amputation risk.

• The biologics segment dominated the market in 2025, due to their effectiveness in accelerating wound healing and tissue regeneration in chronic ulcers.

• The neuro-ischemic ulcers segment dominated the market in 2025 and is also expected to grow fastest in the forecast period. The segment growth is attributed to the increasing prevalence of diabetes-associated neuropathy and peripheral arterial disease among aging patients.

• The mild diabetic foot ulcer (superficial) segment dominated the market in 2025, driven by increasing focus on early diagnosis, preventive diabetic foot care, and timely wound management.

• The hospitals segment dominated the market in 2025 due to the high volume of patient admissions for severe ulcers, infections, and surgical interventions, including debridement and amputation-prevention procedures

• North America diabetic foot ulcer treatment industry dominated the global market in 2025, accounting for a market share of 38.00%. Due to increasing demand for advanced wound care products and medical fixation materials.

Diabetic Foot Ulcer Treatment Market Segmentation

Grand View Research has segmented the global diabetic foot ulcer treatment market report based on treatment, ulcer, wound stage / severity, end use, and region:

Diabetic Foot Ulcer Treatment Treatment Outlook (Revenue, USD Million, 2021 - 2033)

• Advanced Wound Dressings

  • Hydrogel Dressings

    • Amorphous hydrogels

    • Sheet hydrogels

  • Foam Dressings

  • Alginate Dressings

  • Hydrocolloids

  • Film Dressing

  • Collagen Dressings

  • Antimicrobial Dressings

• Biologics

  • Growth Factors

  • Skin Grafts

    • Biological

    • Synthetic

    • Bio-Synthetic

• Therapy Devices

  • Negative Pressure Wound Therapy

  • Ultrasound Therapy

  • Hyperbaric Oxygen Therapy (HBOT)

• Antibiotic Medications

• Others

Diabetic Foot Ulcer Treatment Ulcer Outlook (Revenue, USD Million, 2021 - 2033)

• Neuropathic Diabetic Foot Ulcer

• Ischemic Diabetic Foot Ulcer

• Neuro-ischemic Ulcers

Diabetic Foot Ulcer Treatment Wound Stage / Severity Outlook (Revenue, USD Million, 2021 - 2033)

• Mild DFU (superficial)

• Moderate DFU

• Severe DFU

Diabetic Foot Ulcer Treatment End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Hospitals

• Ambulatory Surgical Centers (Ascs)

• Wound Care Clinics

• Long-Term Care Facilities

• Homecare Settings

Diabetic Foot Ulcer Treatment Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Diabetic Foot Ulcer Treatment Market

• ConvaTec Group PLC

• 3M (Solventum)

• Coloplast Corp.

• Medline Industries, Inc.

• Smith+Nephew

• B. Braun SE

• Cardinal Health

• Organogenesis, Inc.

• Mölnlycke Health Care AB

• Medtronic

• PolyNovo Limited (Metabolic Pharmaceuticals Ltd)

• BioTissue (BioStem Technologies, Inc.)

• Integra LifeSciences

• MIMEDX Group, Inc.

• Biocomposites

• Stedical Scientific, Inc. (PermeaDerm)

• Zimmer Biomet

• GUNZE LIMITED